Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination

A Patja1, M Paunio, E Kinnunen

  • 1Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland.

The Journal of Pediatrics
|February 15, 2001
PubMed
Abstract

Insights

Measles-mumps-rubella (MMR) vaccination does not cause Guillain-Barré syndrome (GBS). This study found no increased risk or causal link between MMR vaccine and GBS onset in Finnish individuals.

Area of Science:

  • Immunology
  • Neurology
  • Vaccinology

Background:

  • Guillain-Barré syndrome (GBS) is a rare neurological disorder.
  • The measles-mumps-rubella (MMR) vaccine is widely administered.
  • A potential association between MMR vaccination and GBS has been investigated.

Purpose of the Study:

  • To investigate the potential causal relationship between MMR vaccination and the incidence of GBS.
  • To determine if MMR vaccine administration increases GBS risk.

Main Methods:

  • An active retrospective study design was employed.
  • Linked nationwide hospital discharge records with individual vaccination data in Finland (1982-1986).
  • Included all patients hospitalized for GBS during the study period.

Main Results:

  • No increase in GBS incidence was observed following MMR vaccination.
  • No temporal clustering of GBS cases occurred after vaccination.
  • The time interval between MMR vaccination and GBS onset exceeded the established 6-week risk period in all cases.
  • Preceding respiratory or gastrointestinal infections were common before GBS onset.

Conclusions:

  • The study found no evidence to support a causal association between MMR vaccination and GBS.
  • MMR vaccination does not appear to increase the risk of developing GBS.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...